Global Parkinson’s Disease Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions.
LPI (LP Information)' newest research report, the “Parkinson’s Disease Treatment Industry Forecast” looks at past sales and reviews total world Parkinson’s Disease Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Parkinson’s Disease Treatment sales for 2023 through 2029. With Parkinson’s Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parkinson’s Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Parkinson’s Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Parkinson’s Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parkinson’s Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parkinson’s Disease Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parkinson’s Disease Treatment.
The global Parkinson’s Disease Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Parkinson’s Disease Treatment players cover Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics, Impax Pharmaceuticals, UCB, AbbVie and MSD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson’s Disease Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors such as aging, environmental factors/exposures, and genetic predispositions.
LPI (LP Information)' newest research report, the “Parkinson’s Disease Treatment Industry Forecast” looks at past sales and reviews total world Parkinson’s Disease Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Parkinson’s Disease Treatment sales for 2023 through 2029. With Parkinson’s Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Parkinson’s Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Parkinson’s Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Parkinson’s Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Parkinson’s Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Parkinson’s Disease Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Parkinson’s Disease Treatment.
The global Parkinson’s Disease Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Parkinson’s Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Parkinson’s Disease Treatment players cover Teva, Roche, Prothena, Acorda Therapeutics, Voyager Therapeutics, Impax Pharmaceuticals, UCB, AbbVie and MSD, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson’s Disease Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Oral
- Transdermal
- Subcutaneous
- Intestinal Infusion
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Roche
- Prothena
- Acorda Therapeutics
- Voyager Therapeutics
- Impax Pharmaceuticals
- UCB
- AbbVie
- MSD
- Orion Pharmaceuticals
- Intec Pharma
- NeuroDerm
- Adamas Therapeutics
- Acadia
- Sunovion
- GSK
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson’s Disease Treatment Market Size 2018-2029
2.1.2 Parkinson’s Disease Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Parkinson’s Disease Treatment Segment by Type
2.2.1 Oral
2.2.2 Transdermal
2.2.3 Subcutaneous
2.2.4 Intestinal Infusion
2.3 Parkinson’s Disease Treatment Market Size by Type
2.3.1 Parkinson’s Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
2.4 Parkinson’s Disease Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Parkinson’s Disease Treatment Market Size by Application
2.5.1 Parkinson’s Disease Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
3 PARKINSON’S DISEASE TREATMENT MARKET SIZE BY PLAYER
3.1 Parkinson’s Disease Treatment Market Size Market Share by Players
3.1.1 Global Parkinson’s Disease Treatment Revenue by Players (2018-2023)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Parkinson’s Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE TREATMENT BY REGIONS
4.1 Parkinson’s Disease Treatment Market Size by Regions (2018-2023)
4.2 Americas Parkinson’s Disease Treatment Market Size Growth (2018-2023)
4.3 APAC Parkinson’s Disease Treatment Market Size Growth (2018-2023)
4.4 Europe Parkinson’s Disease Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Parkinson’s Disease Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Parkinson’s Disease Treatment Market Size by Country (2018-2023)
5.2 Americas Parkinson’s Disease Treatment Market Size by Type (2018-2023)
5.3 Americas Parkinson’s Disease Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson’s Disease Treatment Market Size by Region (2018-2023)
6.2 APAC Parkinson’s Disease Treatment Market Size by Type (2018-2023)
6.3 APAC Parkinson’s Disease Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson’s Disease Treatment by Country (2018-2023)
7.2 Europe Parkinson’s Disease Treatment Market Size by Type (2018-2023)
7.3 Europe Parkinson’s Disease Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson’s Disease Treatment by Region (2018-2023)
8.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET FORECAST
10.1 Global Parkinson’s Disease Treatment Forecast by Regions (2024-2029)
10.1.1 Global Parkinson’s Disease Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Parkinson’s Disease Treatment Forecast
10.1.3 APAC Parkinson’s Disease Treatment Forecast
10.1.4 Europe Parkinson’s Disease Treatment Forecast
10.1.5 Middle East & Africa Parkinson’s Disease Treatment Forecast
10.2 Americas Parkinson’s Disease Treatment Forecast by Country (2024-2029)
10.2.1 United States Parkinson’s Disease Treatment Market Forecast
10.2.2 Canada Parkinson’s Disease Treatment Market Forecast
10.2.3 Mexico Parkinson’s Disease Treatment Market Forecast
10.2.4 Brazil Parkinson’s Disease Treatment Market Forecast
10.3 APAC Parkinson’s Disease Treatment Forecast by Region (2024-2029)
10.3.1 China Parkinson’s Disease Treatment Market Forecast
10.3.2 Japan Parkinson’s Disease Treatment Market Forecast
10.3.3 Korea Parkinson’s Disease Treatment Market Forecast
10.3.4 Southeast Asia Parkinson’s Disease Treatment Market Forecast
10.3.5 India Parkinson’s Disease Treatment Market Forecast
10.3.6 Australia Parkinson’s Disease Treatment Market Forecast
10.4 Europe Parkinson’s Disease Treatment Forecast by Country (2024-2029)
10.4.1 Germany Parkinson’s Disease Treatment Market Forecast
10.4.2 France Parkinson’s Disease Treatment Market Forecast
10.4.3 UK Parkinson’s Disease Treatment Market Forecast
10.4.4 Italy Parkinson’s Disease Treatment Market Forecast
10.4.5 Russia Parkinson’s Disease Treatment Market Forecast
10.5 Middle East & Africa Parkinson’s Disease Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Parkinson’s Disease Treatment Market Forecast
10.5.2 South Africa Parkinson’s Disease Treatment Market Forecast
10.5.3 Israel Parkinson’s Disease Treatment Market Forecast
10.5.4 Turkey Parkinson’s Disease Treatment Market Forecast
10.5.5 GCC Countries Parkinson’s Disease Treatment Market Forecast
10.6 Global Parkinson’s Disease Treatment Forecast by Type (2024-2029)
10.7 Global Parkinson’s Disease Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Parkinson’s Disease Treatment Product Offered
11.1.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Parkinson’s Disease Treatment Product Offered
11.2.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Prothena
11.3.1 Prothena Company Information
11.3.2 Prothena Parkinson’s Disease Treatment Product Offered
11.3.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Prothena Main Business Overview
11.3.5 Prothena Latest Developments
11.4 Acorda Therapeutics
11.4.1 Acorda Therapeutics Company Information
11.4.2 Acorda Therapeutics Parkinson’s Disease Treatment Product Offered
11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Acorda Therapeutics Main Business Overview
11.4.5 Acorda Therapeutics Latest Developments
11.5 Voyager Therapeutics
11.5.1 Voyager Therapeutics Company Information
11.5.2 Voyager Therapeutics Parkinson’s Disease Treatment Product Offered
11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Voyager Therapeutics Main Business Overview
11.5.5 Voyager Therapeutics Latest Developments
11.6 Impax Pharmaceuticals
11.6.1 Impax Pharmaceuticals Company Information
11.6.2 Impax Pharmaceuticals Parkinson’s Disease Treatment Product Offered
11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Impax Pharmaceuticals Main Business Overview
11.6.5 Impax Pharmaceuticals Latest Developments
11.7 UCB
11.7.1 UCB Company Information
11.7.2 UCB Parkinson’s Disease Treatment Product Offered
11.7.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 UCB Main Business Overview
11.7.5 UCB Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Parkinson’s Disease Treatment Product Offered
11.8.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 MSD
11.9.1 MSD Company Information
11.9.2 MSD Parkinson’s Disease Treatment Product Offered
11.9.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 MSD Main Business Overview
11.9.5 MSD Latest Developments
11.10 Orion Pharmaceuticals
11.10.1 Orion Pharmaceuticals Company Information
11.10.2 Orion Pharmaceuticals Parkinson’s Disease Treatment Product Offered
11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Orion Pharmaceuticals Main Business Overview
11.10.5 Orion Pharmaceuticals Latest Developments
11.11 Intec Pharma
11.11.1 Intec Pharma Company Information
11.11.2 Intec Pharma Parkinson’s Disease Treatment Product Offered
11.11.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Intec Pharma Main Business Overview
11.11.5 Intec Pharma Latest Developments
11.12 NeuroDerm
11.12.1 NeuroDerm Company Information
11.12.2 NeuroDerm Parkinson’s Disease Treatment Product Offered
11.12.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 NeuroDerm Main Business Overview
11.12.5 NeuroDerm Latest Developments
11.13 Adamas Therapeutics
11.13.1 Adamas Therapeutics Company Information
11.13.2 Adamas Therapeutics Parkinson’s Disease Treatment Product Offered
11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Adamas Therapeutics Main Business Overview
11.13.5 Adamas Therapeutics Latest Developments
11.14 Acadia
11.14.1 Acadia Company Information
11.14.2 Acadia Parkinson’s Disease Treatment Product Offered
11.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Acadia Main Business Overview
11.14.5 Acadia Latest Developments
11.15 Sunovion
11.15.1 Sunovion Company Information
11.15.2 Sunovion Parkinson’s Disease Treatment Product Offered
11.15.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sunovion Main Business Overview
11.15.5 Sunovion Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Parkinson’s Disease Treatment Product Offered
11.16.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson’s Disease Treatment Market Size 2018-2029
2.1.2 Parkinson’s Disease Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Parkinson’s Disease Treatment Segment by Type
2.2.1 Oral
2.2.2 Transdermal
2.2.3 Subcutaneous
2.2.4 Intestinal Infusion
2.3 Parkinson’s Disease Treatment Market Size by Type
2.3.1 Parkinson’s Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
2.4 Parkinson’s Disease Treatment Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Pharmacy
2.5 Parkinson’s Disease Treatment Market Size by Application
2.5.1 Parkinson’s Disease Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
3 PARKINSON’S DISEASE TREATMENT MARKET SIZE BY PLAYER
3.1 Parkinson’s Disease Treatment Market Size Market Share by Players
3.1.1 Global Parkinson’s Disease Treatment Revenue by Players (2018-2023)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Parkinson’s Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE TREATMENT BY REGIONS
4.1 Parkinson’s Disease Treatment Market Size by Regions (2018-2023)
4.2 Americas Parkinson’s Disease Treatment Market Size Growth (2018-2023)
4.3 APAC Parkinson’s Disease Treatment Market Size Growth (2018-2023)
4.4 Europe Parkinson’s Disease Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Parkinson’s Disease Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Parkinson’s Disease Treatment Market Size by Country (2018-2023)
5.2 Americas Parkinson’s Disease Treatment Market Size by Type (2018-2023)
5.3 Americas Parkinson’s Disease Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson’s Disease Treatment Market Size by Region (2018-2023)
6.2 APAC Parkinson’s Disease Treatment Market Size by Type (2018-2023)
6.3 APAC Parkinson’s Disease Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson’s Disease Treatment by Country (2018-2023)
7.2 Europe Parkinson’s Disease Treatment Market Size by Type (2018-2023)
7.3 Europe Parkinson’s Disease Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson’s Disease Treatment by Region (2018-2023)
8.2 Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON’S DISEASE TREATMENT MARKET FORECAST
10.1 Global Parkinson’s Disease Treatment Forecast by Regions (2024-2029)
10.1.1 Global Parkinson’s Disease Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Parkinson’s Disease Treatment Forecast
10.1.3 APAC Parkinson’s Disease Treatment Forecast
10.1.4 Europe Parkinson’s Disease Treatment Forecast
10.1.5 Middle East & Africa Parkinson’s Disease Treatment Forecast
10.2 Americas Parkinson’s Disease Treatment Forecast by Country (2024-2029)
10.2.1 United States Parkinson’s Disease Treatment Market Forecast
10.2.2 Canada Parkinson’s Disease Treatment Market Forecast
10.2.3 Mexico Parkinson’s Disease Treatment Market Forecast
10.2.4 Brazil Parkinson’s Disease Treatment Market Forecast
10.3 APAC Parkinson’s Disease Treatment Forecast by Region (2024-2029)
10.3.1 China Parkinson’s Disease Treatment Market Forecast
10.3.2 Japan Parkinson’s Disease Treatment Market Forecast
10.3.3 Korea Parkinson’s Disease Treatment Market Forecast
10.3.4 Southeast Asia Parkinson’s Disease Treatment Market Forecast
10.3.5 India Parkinson’s Disease Treatment Market Forecast
10.3.6 Australia Parkinson’s Disease Treatment Market Forecast
10.4 Europe Parkinson’s Disease Treatment Forecast by Country (2024-2029)
10.4.1 Germany Parkinson’s Disease Treatment Market Forecast
10.4.2 France Parkinson’s Disease Treatment Market Forecast
10.4.3 UK Parkinson’s Disease Treatment Market Forecast
10.4.4 Italy Parkinson’s Disease Treatment Market Forecast
10.4.5 Russia Parkinson’s Disease Treatment Market Forecast
10.5 Middle East & Africa Parkinson’s Disease Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Parkinson’s Disease Treatment Market Forecast
10.5.2 South Africa Parkinson’s Disease Treatment Market Forecast
10.5.3 Israel Parkinson’s Disease Treatment Market Forecast
10.5.4 Turkey Parkinson’s Disease Treatment Market Forecast
10.5.5 GCC Countries Parkinson’s Disease Treatment Market Forecast
10.6 Global Parkinson’s Disease Treatment Forecast by Type (2024-2029)
10.7 Global Parkinson’s Disease Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Parkinson’s Disease Treatment Product Offered
11.1.3 Teva Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Parkinson’s Disease Treatment Product Offered
11.2.3 Roche Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Prothena
11.3.1 Prothena Company Information
11.3.2 Prothena Parkinson’s Disease Treatment Product Offered
11.3.3 Prothena Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Prothena Main Business Overview
11.3.5 Prothena Latest Developments
11.4 Acorda Therapeutics
11.4.1 Acorda Therapeutics Company Information
11.4.2 Acorda Therapeutics Parkinson’s Disease Treatment Product Offered
11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Acorda Therapeutics Main Business Overview
11.4.5 Acorda Therapeutics Latest Developments
11.5 Voyager Therapeutics
11.5.1 Voyager Therapeutics Company Information
11.5.2 Voyager Therapeutics Parkinson’s Disease Treatment Product Offered
11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Voyager Therapeutics Main Business Overview
11.5.5 Voyager Therapeutics Latest Developments
11.6 Impax Pharmaceuticals
11.6.1 Impax Pharmaceuticals Company Information
11.6.2 Impax Pharmaceuticals Parkinson’s Disease Treatment Product Offered
11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Impax Pharmaceuticals Main Business Overview
11.6.5 Impax Pharmaceuticals Latest Developments
11.7 UCB
11.7.1 UCB Company Information
11.7.2 UCB Parkinson’s Disease Treatment Product Offered
11.7.3 UCB Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 UCB Main Business Overview
11.7.5 UCB Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Parkinson’s Disease Treatment Product Offered
11.8.3 AbbVie Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 MSD
11.9.1 MSD Company Information
11.9.2 MSD Parkinson’s Disease Treatment Product Offered
11.9.3 MSD Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 MSD Main Business Overview
11.9.5 MSD Latest Developments
11.10 Orion Pharmaceuticals
11.10.1 Orion Pharmaceuticals Company Information
11.10.2 Orion Pharmaceuticals Parkinson’s Disease Treatment Product Offered
11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Orion Pharmaceuticals Main Business Overview
11.10.5 Orion Pharmaceuticals Latest Developments
11.11 Intec Pharma
11.11.1 Intec Pharma Company Information
11.11.2 Intec Pharma Parkinson’s Disease Treatment Product Offered
11.11.3 Intec Pharma Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Intec Pharma Main Business Overview
11.11.5 Intec Pharma Latest Developments
11.12 NeuroDerm
11.12.1 NeuroDerm Company Information
11.12.2 NeuroDerm Parkinson’s Disease Treatment Product Offered
11.12.3 NeuroDerm Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 NeuroDerm Main Business Overview
11.12.5 NeuroDerm Latest Developments
11.13 Adamas Therapeutics
11.13.1 Adamas Therapeutics Company Information
11.13.2 Adamas Therapeutics Parkinson’s Disease Treatment Product Offered
11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Adamas Therapeutics Main Business Overview
11.13.5 Adamas Therapeutics Latest Developments
11.14 Acadia
11.14.1 Acadia Company Information
11.14.2 Acadia Parkinson’s Disease Treatment Product Offered
11.14.3 Acadia Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Acadia Main Business Overview
11.14.5 Acadia Latest Developments
11.15 Sunovion
11.15.1 Sunovion Company Information
11.15.2 Sunovion Parkinson’s Disease Treatment Product Offered
11.15.3 Sunovion Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Sunovion Main Business Overview
11.15.5 Sunovion Latest Developments
11.16 GSK
11.16.1 GSK Company Information
11.16.2 GSK Parkinson’s Disease Treatment Product Offered
11.16.3 GSK Parkinson’s Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 GSK Main Business Overview
11.16.5 GSK Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Parkinson’s Disease Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Transdermal
Table 4. Major Players of Subcutaneous
Table 5. Major Players of Intestinal Infusion
Table 6. Parkinson’s Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 9. Parkinson’s Disease Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Parkinson’s Disease Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Parkinson’s Disease Treatment Revenue Market Share by Player (2018-2023)
Table 14. Parkinson’s Disease Treatment Key Players Head office and Products Offered
Table 15. Parkinson’s Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Parkinson’s Disease Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Parkinson’s Disease Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Parkinson’s Disease Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Parkinson’s Disease Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Parkinson’s Disease Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Parkinson’s Disease Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Parkinson’s Disease Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Parkinson’s Disease Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Parkinson’s Disease Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Parkinson’s Disease Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Parkinson’s Disease Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Parkinson’s Disease Treatment
Table 47. Key Market Challenges & Risks of Parkinson’s Disease Treatment
Table 48. Key Industry Trends of Parkinson’s Disease Treatment
Table 49. Global Parkinson’s Disease Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Parkinson’s Disease Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Parkinson’s Disease Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Teva Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 54. Teva Parkinson’s Disease Treatment Product Offered
Table 55. Teva Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Teva Main Business
Table 57. Teva Latest Developments
Table 58. Roche Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 59. Roche Parkinson’s Disease Treatment Product Offered
Table 60. Roche Main Business
Table 61. Roche Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Roche Latest Developments
Table 63. Prothena Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 64. Prothena Parkinson’s Disease Treatment Product Offered
Table 65. Prothena Main Business
Table 66. Prothena Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Prothena Latest Developments
Table 68. Acorda Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 69. Acorda Therapeutics Parkinson’s Disease Treatment Product Offered
Table 70. Acorda Therapeutics Main Business
Table 71. Acorda Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Acorda Therapeutics Latest Developments
Table 73. Voyager Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 74. Voyager Therapeutics Parkinson’s Disease Treatment Product Offered
Table 75. Voyager Therapeutics Main Business
Table 76. Voyager Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Voyager Therapeutics Latest Developments
Table 78. Impax Pharmaceuticals Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 79. Impax Pharmaceuticals Parkinson’s Disease Treatment Product Offered
Table 80. Impax Pharmaceuticals Main Business
Table 81. Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Impax Pharmaceuticals Latest Developments
Table 83. UCB Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 84. UCB Parkinson’s Disease Treatment Product Offered
Table 85. UCB Main Business
Table 86. UCB Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. UCB Latest Developments
Table 88. AbbVie Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 89. AbbVie Parkinson’s Disease Treatment Product Offered
Table 90. AbbVie Main Business
Table 91. AbbVie Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. AbbVie Latest Developments
Table 93. MSD Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 94. MSD Parkinson’s Disease Treatment Product Offered
Table 95. MSD Main Business
Table 96. MSD Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. MSD Latest Developments
Table 98. Orion Pharmaceuticals Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 99. Orion Pharmaceuticals Parkinson’s Disease Treatment Product Offered
Table 100. Orion Pharmaceuticals Main Business
Table 101. Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Orion Pharmaceuticals Latest Developments
Table 103. Intec Pharma Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 104. Intec Pharma Parkinson’s Disease Treatment Product Offered
Table 105. Intec Pharma Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Intec Pharma Main Business
Table 107. Intec Pharma Latest Developments
Table 108. NeuroDerm Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 109. NeuroDerm Parkinson’s Disease Treatment Product Offered
Table 110. NeuroDerm Main Business
Table 111. NeuroDerm Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. NeuroDerm Latest Developments
Table 113. Adamas Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 114. Adamas Therapeutics Parkinson’s Disease Treatment Product Offered
Table 115. Adamas Therapeutics Main Business
Table 116. Adamas Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Adamas Therapeutics Latest Developments
Table 118. Acadia Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 119. Acadia Parkinson’s Disease Treatment Product Offered
Table 120. Acadia Main Business
Table 121. Acadia Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Acadia Latest Developments
Table 123. Sunovion Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 124. Sunovion Parkinson’s Disease Treatment Product Offered
Table 125. Sunovion Main Business
Table 126. Sunovion Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Sunovion Latest Developments
Table 128. GSK Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 129. GSK Parkinson’s Disease Treatment Product Offered
Table 130. GSK Main Business
Table 131. GSK Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. GSK Latest Developments
Table 1. Parkinson’s Disease Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Transdermal
Table 4. Major Players of Subcutaneous
Table 5. Major Players of Intestinal Infusion
Table 6. Parkinson’s Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 9. Parkinson’s Disease Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 12. Global Parkinson’s Disease Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Parkinson’s Disease Treatment Revenue Market Share by Player (2018-2023)
Table 14. Parkinson’s Disease Treatment Key Players Head office and Products Offered
Table 15. Parkinson’s Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Parkinson’s Disease Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Parkinson’s Disease Treatment Market Size Market Share by Regions (2018-2023)
Table 20. Global Parkinson’s Disease Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Parkinson’s Disease Treatment Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Parkinson’s Disease Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Parkinson’s Disease Treatment Market Size Market Share by Country (2018-2023)
Table 24. Americas Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 26. Americas Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 28. APAC Parkinson’s Disease Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Parkinson’s Disease Treatment Market Size Market Share by Region (2018-2023)
Table 30. APAC Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 32. APAC Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 34. Europe Parkinson’s Disease Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Parkinson’s Disease Treatment Market Size Market Share by Country (2018-2023)
Table 36. Europe Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 38. Europe Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Parkinson’s Disease Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Parkinson’s Disease Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Parkinson’s Disease Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Parkinson’s Disease Treatment
Table 47. Key Market Challenges & Risks of Parkinson’s Disease Treatment
Table 48. Key Industry Trends of Parkinson’s Disease Treatment
Table 49. Global Parkinson’s Disease Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Parkinson’s Disease Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Parkinson’s Disease Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Teva Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 54. Teva Parkinson’s Disease Treatment Product Offered
Table 55. Teva Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Teva Main Business
Table 57. Teva Latest Developments
Table 58. Roche Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 59. Roche Parkinson’s Disease Treatment Product Offered
Table 60. Roche Main Business
Table 61. Roche Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Roche Latest Developments
Table 63. Prothena Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 64. Prothena Parkinson’s Disease Treatment Product Offered
Table 65. Prothena Main Business
Table 66. Prothena Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Prothena Latest Developments
Table 68. Acorda Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 69. Acorda Therapeutics Parkinson’s Disease Treatment Product Offered
Table 70. Acorda Therapeutics Main Business
Table 71. Acorda Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Acorda Therapeutics Latest Developments
Table 73. Voyager Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 74. Voyager Therapeutics Parkinson’s Disease Treatment Product Offered
Table 75. Voyager Therapeutics Main Business
Table 76. Voyager Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Voyager Therapeutics Latest Developments
Table 78. Impax Pharmaceuticals Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 79. Impax Pharmaceuticals Parkinson’s Disease Treatment Product Offered
Table 80. Impax Pharmaceuticals Main Business
Table 81. Impax Pharmaceuticals Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Impax Pharmaceuticals Latest Developments
Table 83. UCB Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 84. UCB Parkinson’s Disease Treatment Product Offered
Table 85. UCB Main Business
Table 86. UCB Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. UCB Latest Developments
Table 88. AbbVie Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 89. AbbVie Parkinson’s Disease Treatment Product Offered
Table 90. AbbVie Main Business
Table 91. AbbVie Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. AbbVie Latest Developments
Table 93. MSD Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 94. MSD Parkinson’s Disease Treatment Product Offered
Table 95. MSD Main Business
Table 96. MSD Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. MSD Latest Developments
Table 98. Orion Pharmaceuticals Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 99. Orion Pharmaceuticals Parkinson’s Disease Treatment Product Offered
Table 100. Orion Pharmaceuticals Main Business
Table 101. Orion Pharmaceuticals Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Orion Pharmaceuticals Latest Developments
Table 103. Intec Pharma Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 104. Intec Pharma Parkinson’s Disease Treatment Product Offered
Table 105. Intec Pharma Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. Intec Pharma Main Business
Table 107. Intec Pharma Latest Developments
Table 108. NeuroDerm Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 109. NeuroDerm Parkinson’s Disease Treatment Product Offered
Table 110. NeuroDerm Main Business
Table 111. NeuroDerm Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 112. NeuroDerm Latest Developments
Table 113. Adamas Therapeutics Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 114. Adamas Therapeutics Parkinson’s Disease Treatment Product Offered
Table 115. Adamas Therapeutics Main Business
Table 116. Adamas Therapeutics Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 117. Adamas Therapeutics Latest Developments
Table 118. Acadia Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 119. Acadia Parkinson’s Disease Treatment Product Offered
Table 120. Acadia Main Business
Table 121. Acadia Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 122. Acadia Latest Developments
Table 123. Sunovion Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 124. Sunovion Parkinson’s Disease Treatment Product Offered
Table 125. Sunovion Main Business
Table 126. Sunovion Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 127. Sunovion Latest Developments
Table 128. GSK Details, Company Type, Parkinson’s Disease Treatment Area Served and Its Competitors
Table 129. GSK Parkinson’s Disease Treatment Product Offered
Table 130. GSK Main Business
Table 131. GSK Parkinson’s Disease Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 132. GSK Latest Developments
LIST OF FIGURES
Figure 1. Parkinson’s Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson’s Disease Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Parkinson’s Disease Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Parkinson’s Disease Treatment Sales Market Share by Country/Region (2022)
Figure 8. Parkinson’s Disease Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Parkinson’s Disease Treatment Market Size Market Share by Type in 2022
Figure 10. Parkinson’s Disease Treatment in Hospital Pharmacy
Figure 11. Global Parkinson’s Disease Treatment Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Parkinson’s Disease Treatment in Retail Pharmacy
Figure 13. Global Parkinson’s Disease Treatment Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Parkinson’s Disease Treatment in Online Pharmacy
Figure 15. Global Parkinson’s Disease Treatment Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 16. Global Parkinson’s Disease Treatment Market Size Market Share by Application in 2022
Figure 17. Global Parkinson’s Disease Treatment Revenue Market Share by Player in 2022
Figure 18. Global Parkinson’s Disease Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Parkinson’s Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Parkinson’s Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Parkinson’s Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Parkinson’s Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Parkinson’s Disease Treatment Value Market Share by Country in 2022
Figure 24. United States Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Parkinson’s Disease Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Parkinson’s Disease Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Parkinson’s Disease Treatment Market Size Market Share by Application in 2022
Figure 31. China Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Parkinson’s Disease Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Parkinson’s Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson’s Disease Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Parkinson’s Disease Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Parkinson’s Disease Treatment Sales Market Share by Country/Region (2022)
Figure 8. Parkinson’s Disease Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Parkinson’s Disease Treatment Market Size Market Share by Type in 2022
Figure 10. Parkinson’s Disease Treatment in Hospital Pharmacy
Figure 11. Global Parkinson’s Disease Treatment Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Parkinson’s Disease Treatment in Retail Pharmacy
Figure 13. Global Parkinson’s Disease Treatment Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Parkinson’s Disease Treatment in Online Pharmacy
Figure 15. Global Parkinson’s Disease Treatment Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 16. Global Parkinson’s Disease Treatment Market Size Market Share by Application in 2022
Figure 17. Global Parkinson’s Disease Treatment Revenue Market Share by Player in 2022
Figure 18. Global Parkinson’s Disease Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Parkinson’s Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Parkinson’s Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Parkinson’s Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Parkinson’s Disease Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Parkinson’s Disease Treatment Value Market Share by Country in 2022
Figure 24. United States Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Parkinson’s Disease Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Parkinson’s Disease Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Parkinson’s Disease Treatment Market Size Market Share by Application in 2022
Figure 31. China Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Parkinson’s Disease Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Parkinson’s Disease Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Parkinson’s Disease Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Parkinson’s Disease Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Parkinson’s Disease Treatment Market Size Market Share Forecast by Application (2024-2029)
